Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy. - sprookjes - yvandenbroek - TriplyDB

Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy.

Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy.

http://www.wikidata.org/entity/Q37500522

about

Intravitreal bevacizumab in treatment of retinal neovascularization from tuberculous retinal vasculitis.Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy

P2860

Q49676839-2598B7EA-7A06-455C-AC5B-D64C65C43BDC Q58130274-7EBCD1E7-5FFB-41FC-A7EE-81426A398648

P2860

Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy.

http://www.wikidata.org/entity/Q37500522

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Panretinal photocoagulation ve ...... ferative diabetic retinopathy.

@en

Panretinal photocoagulation ve ...... ferative diabetic retinopathy.

@nl

type

label

Panretinal photocoagulation ve ...... ferative diabetic retinopathy.

@en

Panretinal photocoagulation ve ...... ferative diabetic retinopathy.

@nl

prefLabel

Panretinal photocoagulation ve ...... ferative diabetic retinopathy.

@en

Panretinal photocoagulation ve ...... ferative diabetic retinopathy.

@nl

P1433

Q37500522-0B4675FF-CF03-4B61-9208-BE2355F25136

P1476

Q37500522-E0C7DB29-1AE3-4DD5-B8E5-E61A22DD57CC

P2093

Q37500522-234B9388-1236-4E69-AC43-34772CE5625E

Q37500522-729D9169-6BD9-4874-A76E-1A0D72764F6E

Q37500522-C9A75343-7483-4703-91D2-2B1242464E9D

Q37500522-ECAB445E-3870-4157-AEEA-DC7EBD6E5971

Q37500522-F1B372DF-17D9-42FE-A663-14AB667565FF

Q37500522-F62A1625-6B19-47D7-8030-D57DFAC67378

P2860

Q37500522-05FF4634-4A0C-4E8D-8C45-9143D8340234

Q37500522-09988FFF-6DEF-45D3-8D30-4FBFBD67C599

Q37500522-1A6EF95A-B548-4F06-9658-06B5626B2456

Q37500522-1DEE612C-66BC-4311-8D83-86944659E421

Q37500522-397E4A47-9178-4419-9380-036634F9678A

Q37500522-3DD2B4BF-23EC-4358-9DC1-47AFB9B12C0E

Q37500522-441E2FE0-32B6-448A-9C96-E9B645A2A7D6

Q37500522-54F68C5A-4C50-463D-8555-F8CC92734A38

Q37500522-6EC17A0A-0F41-438F-8A9D-D3EA7F7E298B

Q37500522-720762C4-076D-498E-B42B-E5FFDC21EFC2

P304

Q37500522-EA706D3F-45B7-4E2D-BD9A-31D490245033

P31

Q37500522-3B9B8959-5FA8-4A81-9B74-C60E469E6572

P356

Q37500522-FC1A9BEB-2A8A-4581-9671-106F73619382

P433

Q37500522-77D1EC83-9AF8-4EA8-A24E-802356DCE6A6

P478

Q37500522-CE40CD92-6FFA-437B-A4B7-C7E21C6BD0C0

P577

Q37500522-30AC7D41-18C0-455B-8DF2-ABC6219593EB

P698

Q37500522-C0D2020E-3AEF-420F-80DB-68A54A607783

P921

Q37500522-0F7D10DA-5F18-453C-B7A7-9C2A280B58AF

Q37500522-E0C6CEED-EA2A-4F7A-9D66-DF10F868BFBA

P932

Q37500522-CEC13065-609A-4274-81CB-0C4433CDED2D

P356

P1433

International Journal of Ophthalmology

P1476

Panretinal photocoagulation ve ...... ferative diabetic retinopathy.

@en

P2093

Ai-Yi Zhou

http://www.w3.org/2001/XMLSchema#string

Bai-Chao Ren

http://www.w3.org/2001/XMLSchema#string

Chen-Jing Zhou

http://www.w3.org/2001/XMLSchema#string

Jian-Ming Wang

http://www.w3.org/2001/XMLSchema#string

Jing Yao

http://www.w3.org/2001/XMLSchema#string

Yan-Long Quan

http://www.w3.org/2001/XMLSchema#string

P2860

A review of therapies for diabetic macular oedema and rationale for combination therapy

Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study).

Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group.

Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy.

Effects of an intravitreal bevacizumab injection combined with panretinal photocoagulation on high-risk proliferative diabetic retinopathy

Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy.

Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy.

Vitreous and plasma VEGF levels as predictive factors in the progression of proliferative diabetic retinopathy after vitrectomy

Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.

Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial.

P304

1772-1778

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18240/IJO.2016.12.12

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28003978

http://www.w3.org/2001/XMLSchema#string

P921

Light Coagulation

P932

5154991

http://www.w3.org/2001/XMLSchema#string